We are appalled by the recently released Commission on Audit (COA) 2023 report on the Department of Education’s (DepEd) projects worth P1.064 billion down the drain. The implementation of the DepEd ...

Analyst Daina Graybosch of Leerink Partners maintained a Buy rating on Merck & Company (MRK – Research Report), reducing the price target to $119.00. Discover outperforming stocks and invest ...

JPM25 is in full swing as several pharma powerhouses—including Merck, Lilly and Amgen—detail their strategies for growth in the coming year. After an explosive opening marked by a suite of ...

In separate presentations, the CEOs of Bristol Myers Squibb, Pfizer and Merck laid out their plans to overcome high-profile losses of exclusivity (LOEs) slated to dent sales through the end of the ...

In a recent collaboration, Turbotech, Safran, and Air Liquide teamed up to validate the feasibility of using liquid hydrogen to power a turbine engine for light aircraft. Nearly a year ago to this ...

Merck & Co. expects to launch an easier-to-administer version of its blockbuster cancer treatment Keytruda before the end of the year, accelerating the company’s efforts to protect its top ...

Executives at Amgen made the case for MariTide’s differentiation, while Merck’s CEO contended that Keytruda’s coming loss of exclusivity can be managed. SAN FRANCISCO — For any hopes the dealmaking ...

Naturally occurring hydrogen has been detected in Tumut and parts of western NSW, sparking Labor hopes that the fledgling sector could be spurred by ambitious minerals explorers wanting to drill ...

A thorough analysis of market, technological, and supply chain outcomes for sodium-ion batteries finds that significant advances are needed before commercialization. Legions of battery engineers ...

The STEER team also plans to analyze technology roadmaps in long-duration energy storage, as well as other energy transition areas such as hydrogen and industrial decarbonization. More information: ...